Attached files

file filename
EX-99.1 - PRESS RELEASE - Dehaier Medical Systems Ltdv324259_ex99-1.htm




Washington, D.C. 20549





Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934


Date of report (date of earliest event reported): September 21, 2012




 (Exact name of registrant as specified in its charter)


British Virgin Islands   001-34661   Not Applicable

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)


Suite 501, Jiuzhou Plaza

83 Fuxing Road, Haidian District

Beijing 100856 China

(Address of principal executive offices, including zip code)


+86 (10) 5166-0080

(Registrant’s telephone number, including area code)


Not Applicable

(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Item 8.01.          Other Events.


On September 21, 2012, the Registrant issued a press release announcing that it had entered into a procurement agreement with a Ukrainian medical device manufacturer, by which the Registrant’s air compressors, customized trolleys and accessories may be sold in Ukraine and Europe through the manufacturer’s sales network.


A copy of the press release announcing the agreement is attached hereto as Exhibit 99.1.


Item 9.01.          Financial Statements and Exhibits.




99.1Press release dated September 21, 2012, titled “Dehaier Medical Wins Three Year Procurement Agreement from Major Ukrainian Medical Equipment Manufacturer.”




Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


  Dehaier Medical Systems Limited
  By: /s/ Ping Chen
    Ping Chen
    Chief Executive Officer


Dated: September 25, 2012